Alliance of U.S. Startups and Inventors for Jobs

We just released a new one-page guide on how the Trump administration and Congress can build on the momentum of the 2026 Special 301 Report. Check it out! 👇 usij.org/usij-one-pager-turn…

The RESTORE Patent Rights Act would: -- Return the presumption of injunctive relief in cases where a court has ruled that a patent has been infringed. -- Make "efficient infringement" a less attractive business strategy. -- Incentivize innovation, investment, and startup activity by making patents more reliable and enforceable. We call on lawmakers to advance the RESTORE Patent Rights Act to help protect innovation by American startups and small companies. Learn more in our statement praising the bill's reintroduction: buff.ly/v2rwWNI.

.@USIJorg applauds USPTO Director Squires for the NPRM, which would protect American startups and little tech. Learn more about these important reforms here: buff.ly/WEdC24j

⬇️ ⬇️ ⬇️

ICYMI: Our newest amicus brief, submitted for Centripetal Networks, LLC v. Cisco Systems, Inc., urges the Supreme Court to grant certiorari and reverse a Federal Circuit decision that erased a judgment of more than $2 billion against Cisco for willful infringement of Centripetal’s cybersecurity patents. Check out the full amicus brief here: buff.ly/QyIx78n

💡 💡 💡

DYK IP is a positive driver of trade for the United States? Learn more from @Council4IP's David Kappos: buff.ly/i15nojO

.@IPWatchdog just covered our newest amicus brief. Learn more about why we're supporting Centripetal here: buff.ly/GJsiMjt

Since its inception, USIJ has been a leading advocate against misguided proposals that endanger IP rights. More about how we support America's inventors: usij.org/

In recent years, legal loopholes and court decisions have left patent owners facing repetitive litigation and parallel challenges in federal court and before the USPTO’s Patent Trial and Appeal Board (PTAB). Learn why lawmakers must protect innovation: buff.ly/VsKra9r

We urge lawmakers to reject the ETHIC Act. The bill is premised on misconceptions about how patent law works and ignores the strong safeguards already built into the patent system. There is also no clear empirical evidence of so-called "patent thickets" as a widespread problem. Learn more in our letter to the House Judiciary Committee: buff.ly/RzwBtxn

In our new amicus brief, we contend a Federal Circuit decision deprived Centripetal of due process and signals to startups and their investors that U.S. patents offer little protection against copying by dominant incumbents, further eroding investment in patent-intensive technologies. See the full amicus brief:buff.ly/QyIx78n

Last week, @USIJorg filed an amicus brief in Centripetal Networks, LLC v. Cisco Systems, Inc. urging the Supreme Court to grant certiorari and reverse a Federal Circuit decision that erased a judgment of more than $2 billion against Cisco for willful infringement of Centripetal’s cybersecurity patents. Check out the brief here: buff.ly/QyIx78n

Policy makers have correctly pointed to aggressive efforts from China and other major economies to acquire leading technologies developed by the United States as a part of their strategy to propel their own economic growth. Learn more about why fighting IP theft is, however, only half the battle: buff.ly/ZR9637g

💡 💡 💡

The beneficiary of the PTAB’s inconsistency is a large, often foreign, infringer, while the victim is an American innovator. Learn more in our recent report: buff.ly/ain5Wyc

IP drives American trade. Learn more: buff.ly/i15nojO

"Last year, Trump negotiated a deal that will require Britain to increase what it pays for new medicines by 25%. As Britain contributes more toward developing new medicines, the cost burden on the United States will decrease. The administration is also laying the groundwork for a similar agreement with Germany. In June, it launched a formal investigation into how Germany's drug price controls have harmed American commerce. This investigation will give American trade officials the leverage they need to negotiate fairer pricing policies and practices with German policymakers." Read more from fmr Deputy USTR Jeff Gerrish in @FoxNews: buff.ly/3sPkUKQ

Learn why we support the PREVAIL Act: buff.ly/QqqZPPm

Overall growth in venture capital investment can obscure an important trend: a declining share of funding is flowing to R&D-intensive sectors such as semiconductors, fiber optics, drug discovery, networking equipment, medical devices, biotechnology, and computer hardware. These are foundational technologies with significant implications for U.S. economic competitiveness and national security. Learn more: buff.ly/ZR9637g